Intrapulmonary delivery of polypeptide growth factors and cytoki

Details Intrapulmonary delivery of polypeptide growth factors and cytoki Intrapulmonary delivery of polypeptide growth factors and cytoki

1993-09-27

2000-08-08

Bockelman, Mark

Surgery

Means for introducing or removing material from body for...

Treating material introduced into or removed from body...

A61K 914

Patent

active

060995173

ABSTRACT:
Polypeptides selected from the group of growth factors and cytokines are administered by intrapulmonary inhalation. Disclosed are novel compositions and devices for effecting the intrapulmonary administration of these polypeptides.

REFERENCES:
Wigley et al., "Insulin Across Respiratory Mucosae by Aerosol Delivery", Diabetes, 20(8):552-556 (1971).
Mutch, "Inhalation of Chemotherapeutic Substances", The Lancet, Dec. 16, 1944 pp. 775-780.
Greenberg et al., "Prophylatic Effect of Low Doses of Human Leukocyte Interferon Against Infection with Rhinovirus", The Journal of Infectious Diseases, 145(4)542-546 (1982).
Sun et al., "Efficacy of Aerosolized Recombinant Interferons Against Vesicular Stomatitis Virus-Induced Lung Infection in Cotton Rats", Journal of Interferon Research, 4:449-454 (1984).
Wyde et al., "Pulmonary Deposition and Clearance of Aerosolized Interferon", Antimicrobial Agents and Chemotherapy, 25(6):729-734 (1984).
Wyde et al., "Duration of Effect of Interferon Aerosol Prophylaxis of Vesicular Stomatis Virus Infection in Mice", Antim. Agts. and Chemo., 27(1):60-64 (1985).
Sun et al., "Limited Efficacy of Aerosolized Recombinant Alpha Inerferon against Virulent Influenze A/HK Infection in Mice (42257)", Proceedings of the Society for Experimental Biology and Medicine, 181:298-304 (1986).
Jia-xiong et al., "Children's Respiratory Viral Diseases Treated with Interferon Aerosol", Chinese Medical Journal, 100(2):162-166 (1987).
Wyde et al., "Interferon Aerosol Suppression of Vesicular Stomatitis Virus Replication in the Lungs of Infected Mice", Antimicrobial Agents and Chemotherapy, 26(4):450-454 (1984).
Rudent et al., "Enhanced Resistance of Mice Against Influenza Virus Infection after Local Administration of Glycoprotein Extracts from Klebsiella Pneumoniae", Int. J. Immunopharmac. 7(4):525-531 (1985).
Mojard et al., "Differential Responses of Human Asthmatics to Inhaled Vasoactive Intestinal Peptide (VIP)", American Review of Respiratory Disease, 131(4):A281 (1985).
May, "The Collison Nebulizer:Description, Performance and Application", Aerosol Science, 4:235-243 (1973).
Devilbiss Health Care Inc. Catalogue, "Atomizers, Nebulizers, Powder Blowers, Syringes, Irrigators, Compressors."
Primagi et al., "Vaccination by the Aerosol Method", Erkrank Atom, -Org., 150:239-242 (1978).
Murray-Nadel, Textbook of Respiratory Medicine, Chapter 17: "Deposition and Clearance", W.B Saunders & Co., (1988).
Egan, "Lung inflation, lung solute permeability, and alveolar edma", American Physiological Society, pp. 121-125 (1982).
Niewoehner, et al., "Injurios effects of lysophosphatidylcholine on barrier properties of alvolar epithelium", J. Appl. Physiol. 63(5) pp. 1979-1986 (1987).
Gorin et al., "Differential permeability of endothelial and epithelial barriers to albumin flux", American Physiological Society, pp. 1315-1324 (1979).
Schneeberger-Keeley et al., The Ultrastructural Basis of Alveolar-Capillary Membrane Permeability to Peroxidase Used as a Tracer, The Journal of Cell Biology, 37:781-793 (1968).
Williams, "Endocytosis in alveolar type II cells:Effect of charge and size of tracers", Proc. Natl. Acad. Sci. USA, 81:6054-6058 (1984).
Taylor et al., "Permeability of the Alveolar Membrane to Solutes", Circulation Research, XVI:353-362 (1965).
Taylor et al., "Estimation of equivalent pore radii of pulmonary capillary and alveolar membranes", American Journal of Physiology, 218(4):1133-1140 (1970).
Kurzrock et al., "Phase I Study of Multiple Dose Intramuscularly Administered Recombinant Gamma Interferon", Journal of Clinical Oncology, 4(7):1101-1109 (1986).
Matsunaga et al., "Augmentation of In Vitro Cytotoxicity and In Vivo Tumor-Inhibition by Combined Use of Lymphotoxin-Containing Supernatants and Antitumor Drugs", Cancer Letters 20:21-28 (1983).
Neta et al., "Interleukin 1 is a Radioprotector", The Journal of Immunology, 136(7):2483-2485 (1986).
Staruch et al., "The Adjuvanticity of Interleukin 1 In Vivo", The Journal of Immunology, 130(5):2191-2194 (1983).
Nishimura et al., "Administration of slowly released recombinant interleukin 2--Augmentation of the efficacy of adoptive immunotherapy with lymphokine-activated killer (LAK) cells", Journal of Immunological Methods, 91:21-27 (1986).
Rosenberg et al., "A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2", Surgery, 100(2):262-272 (1986).
Ettinghausen et al., "Immunotherapy of Murine Sarcomas Using Lymphokine Activated Killer Cells:Optimization of the Schedule and Route of Administration of Recombinant Interleukin-2", Cancer Research, 46:2784-2792 (1986).
Hubbell et al., "Antiproliferative and Immunodulatory Actions of .beta.-Interferon and Double-Stranded RNA, Individually and in Combination, on Human Bladder Tumor Xenografts in Nude Mice", Cancer Research, 45:2481-2486 (1985).
Preece et al., "Dose Dependence of Growth Response to Human Growth Hormone in Growth Hormone Deficiency", JCE & M, 42(3):477-483 (1976).
Gertner et al., "Prospective Clinical Trials of Human Growth Hormone in Short Children without Growth Hormone Deficiency", The Journal of Pediatrics, 104(2):172-176 (1984).
Rosenbloom et al., "Low Dose Single Weekly Injections of Growth Hormone: Response During First Year of Therapy of Hypopituitarism", Pediatrics, 66(2): 272-276 (1980).
Hallworth et al., "A Comparison of the Regional Deposition in a Model Nose of a Drug Discharged from Metered Aerosol and Metered-Pump Nasal Delivery Systems", J. Allergy Clin. Immunol., 77:348 (1986).
Newman et al., "Deposition Pattern from a Nasal Spray Pump", Rhinology, 25:77 (1987).
Newman et al., "The Nasal Distribution of Metered Dose Inhalers", J. Laryngol. Otol., 101:127 (1987).
Hardy et al., "Intranasal Drug Delivery by Sprays and Drops", J. Pharm. Pharmacol., 37:294 (1985).
Bensch et al., Absorption of Intact Protein Molecules across the Pulmonary Air-Tissue Barrier, Science, vol. 157, pp. 1204-1206 (1967).
Bensch et al., Studies on the Pulmonary Air-Tissue Barrier; Part IV: Cytochemical Trancing of Macromolecules during Adsorption, Yale J. Biol. Med., vol. 43, pp. 236-241 (1971).
Scheeberger et al., Structural Basis for Some Permeability Properties of the Air-Blood Barrier, Fed. Proc. Vol. 37(11), p. 2471 (1978).
Padmanabhan et al., Protection Against Pulmonary Oxygen Toxicity in Rats by the Intratracheal Administration of Liposome-Encapsulated Superoxide Dismutase of Catalase, Am. Rev. Respir. Dis., vol. 132(10, pp. 164-167 (1985).
Richardson et al., Uptake and Transport of Exogenous Proteins by Respiratory Epithelium, Lab. Invest., vol. 35(4), p. 307 (1976).

Affiliated with

Also associated with

Rating

Intrapulmonary delivery of polypeptide growth factors and cytoki does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intrapulmonary delivery of polypeptide growth factors and cytoki, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intrapulmonary delivery of polypeptide growth factors and cytoki will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1145682